Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
ETAMIPHYLLIN CAMSILATE
Dechra Ltd
QR03
140 Mg/Dose
Oral Gel
Respiratory Tract Preparations
Bovine
2005-10-01
IRISH MEDICINES BOARD ACT 1995 ANIMAL REMEDIES REGULATIONS, 2005 (S.I. NO. 734 OF 2005) VPA: 10799/007/001 Case No: 7002834 The Irish Medicines Board in exercise of the powers conferred on it by Animal Remedies Regulations (S.I. No. 734 of 2005) hereby grants to: DECHRA LTD DECHRA HOUSE, JAMAGE INDUSTRIAL ESTATE, STOKE-ON-TRENT ST7 1XW, UNITED KINGDOM an authorisation, subject to the provisions of the said Regulations and the general conditions of the attached authorisation, in respect of the Veterinary Medicinal Product: DALOPHYLLINE 140 MG/DOSE ORAL GEL The particulars of which are set out in Part 1 and Part 2 of the said Schedule. The authorisation is also subject to any special conditions as may be specified in the said Schedule. Signed on behalf of the Irish Medicines Board ________________ A person authorised in that behalf by the said Board. (NOTE: This authorisation replaces any previous authorisation in respect of this product which is now null and void.) IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 20/01/2007_ _CRN 7002834_ _page number: 1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Dalophylline 140 mg Oral Gel 2 QUALITATIVE AND QUANTITATIVE COMPOSITION For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM A colourless, transparent oral gel. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Calves and lambs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Etamiphylline Camsylate is a smooth muscle relaxant and cardiac and respiratory stimulant. It is indicated in the treatment of cardiac and respiratory failure and distress and it may be of use in pneumonia and upper respiratory tract infections. Dalophylline gel is in Read the complete document